COVID-19 updates: Anti-vaccine protesters halt vaccinations at Dodger Stadium

Demonstrators carrying anti-mask and anti-vaccine signs blocked the entrance.

A pandemic of the novel coronavirus has now infected more than 102.5 million people worldwide and killed over 2.2 million of them, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.


0

Monoclonal antibody treatments show promising results

American biotechnology company Regeneron Pharmaceuticals announced Wednesday that its cocktail of two monoclonal antibodies held up in laboratory experiments against new variants of the novel coronavirus first identified in the United Kingdom and South Africa.

Monoclonal antibodies are synthetic versions of our natural antibody defense to infection. They are being studied as a way to both treat and prevent COVID-19 infection, with promising results. But unlike vaccines, which are thought to offer broader protection, some scientists have been worried that this type of therapy would be less effective against newly emerging variants of the virus.

Wednesday's announcement is good news for Regeneron's monoclonal antibody treatment, REGEN-COV, though the data is still preliminary and currently under peer review.

Regeneron scientists as well as researchers at Columbia University in New York City have each independently confirmed that the casirivimab and imdevimab antibody cocktail successfully neutralized both the U.K. and South Africa variants when tested against them, according to a company press release.

REGEN-COV has not yet been tested against another variant that was first identified in Brazil. However, Regeneron said the two-antibody cocktail "is expected to remain similarly potent" based on some resemblance which the Brazil variant bears to the South Africa strain. The company said it is pursuing further confirmatory research.

It's the latest piece of promising news about the efficacy of monoclonal antibodies as treatment for COVID-19. On Tuesday, American pharmaceutical firm Eli Lilly and Company announced that a combination of two monoclonal antibodies, bamlanivimab and etesevimab, was found to be effective in COVID-19 patients at high risk of severe infection, reducing the risk of hospitalization and death by 70%, according to the results of a final-stage trial.

That same day, Regeneron announced its antibody cocktail had shown positive initial results in prophylactic use -- that is, helping ward off COVID-19 in those who may have been exposed to the virus. Regeneron’s chief scientific officer, Dr. George Yancopoulos, said he hopes the drug "may be able to help break this chain" of active infection and transmission.

Last Thursday, Eli Lilly released data showing bamlanivimab may help prevent disease and stop outbreaks among residents and staff of long-term care facilities.

ABC News' Sasha Pezenik contributed to this report.


January is already the deadliest month for COVID-19 in US

January is now already the deadliest month of the coronavirus pandemic for the United States.

So far this month, 79,261 people have lost their lives to COVID-19 in the U.S., surpassing December's record 77,124 deaths, according to real-time data compiled by Johns Hopkins University.

December still holds the record for the highest number of diagnosed COVID-19 cases.

ABC News' Ahmad Hemingway contributed to this report.


Auschwitz survivors mark 76th anniversary online amid pandemic

The official commemoration of the 76th anniversary of Auschwitz's liberation will be held online Wednesday due to the coronavirus pandemic.

The Auschwitz-Birkenau State Museum and Memorial, which is located on the site of the Nazi concentration camp in Oswiecim, Poland, is closed for visitors until at least Jan. 31 under COVID-19 restrictions set by the Polish government.

"Due to the coronavirus pandemic, the commemoration will exceptionally not be held at the Memorial, but in the virtual space," Auschwitz Memorial spokesperson Pawel Sawicki said in a statement Tuesday evening. "The main theme of the 76th anniversary of the liberation will be the fate of children in Auschwitz."

The online events will include testimony from survivors as well as a guided virtual tour of the Auschwitz Memorial, "aimed at enhancing the educational value for visitors from around the globe," according to Sawicki.

Auschwitz, also known as Auschwitz-Birkenau, was a complex of over 40 concentration and death camps run by Nazi Germany in occupied Poland amid the Holocaust during World War II. It was the largest of the Nazi concentration camps and extermination centers. More than 1.1 million men, women and children lost their lives there, mainly Jews, according to information on the Auschwitz-Birkenau State Museum's website.

In January 1945, as Soviet Russia advanced deeper into Nazi-occupied Poland toward the end of the war, Nazi officers organized a forced evacuation of the Auschwitz prisoners. Almost 9,000 prisoners, most of whom were sick or suffering from exhaustion, were deemed unfit to join the death march to Germany. The Nazis intended to kill them all as part of attempts to destroy the evidence of their crimes at Auschwitz, but only managed to murder about 700 Jewish prisoners between the departure of the final evacuation column and the arrival of Soviet forces.

Soviet troops entered Auschwitz on Jan. 27, 1945, a day now commemorated as International Holocaust Remembrance Day, and liberated more than 7,000 survivors, according to the museum's website.


Gambia vows to name and shame those flouting COVID-19 rules

Forty people in Gambia who tested positive for COVID-19 over the past week have refused to self-isolate or have escaped treatment centers, according to the country's health ministry, which vowed to reveal the identities of those flouting public health regulations.

Officials are also aware of a "large number of travelers who recently arrived" in the small West African nation from countries considered COVID-19 hotspots and "have refused to abide to official protocols and/or report to the health authorities for the mandatory test upon arrival," said Modou Njai, director of health promotion and education at Gambia's Ministry of Health.

"The Ministry continues to treat these matters with utmost and grave concern and thus, the Ministry is hereby giving an order and ultimatum to all those concerned, that they are required to report themselves to the health authorities with immediate effect and failure of which will lead to serious consequences, including the publication of names and identifying information of all those at large," Njai said in a statement Tuesday.

"The Ministry would like to stress that this serious and ruthless misconduct will no longer be condoned under any circumstances," he added. "Anyone found not willing to cooperate with COVID-19 regulations will have their names and identifying information published on the media and thereafter, drastic measures will be taken against anyone that is non-compliant."

Gambia, home to some 2.3 million people, has confirmed 4,008 cases of COVID-19 since the start of the pandemic, including at least 128 deaths, according to the latest data from the health ministry.


Fauci describes what it was like working with Trump

Dr. Anthony Fauci, the nation's leading infectious disease expert, opened up about his experience working with former U.S. President Donald Trump in an interview with The New York Times that was published Sunday.

When COVID-19 began to rapidly spread in the northeastern part of the country last year, particularly in New York City, Fauci said Trump had "almost a reflex response" to try to "minimize" the situation.

"I would try to express the gravity of the situation, and the response of the president was always leaning toward, 'Well, it's not that bad, right?' And I would say, 'Yes, it is that bad,'" Fauci, director of the National Institute of Allergy and Infectious Diseases, told the newspaper. "It was almost a reflex response, trying to coax you to minimize it. Not saying, 'I want you to minimize it,' but, 'Oh, really, was it that bad?'"

Fauci, who was a key member of the Trump administration's coronavirus task force, said another thing that made him "really concerned" was the former president taking input from non-experts on unproven methods to treat COVID-19, like hydroxychloroquine.

"It was clear that he was getting input from people who were calling him up, I don’t know who, people he knew from business, saying, 'Hey, I heard about this drug, isn't it great?' or, 'Boy, this convalescent plasma is really phenomenal,'" Fauci told the newspaper. "And I would try to, you know, calmly explain that you find out if something works by doing an appropriate clinical trial; you get the information, you give it a peer review. And he’d say, 'Oh, no, no, no, no, no, no, no, this stuff really works.'"

"He would take just as seriously their opinion -- based on no data, just anecdote -- that something might really be important," Fauci added. "That’s when my anxiety started to escalate."

When the leadership of the White House coronavirus task force changed hands last February, with U.S. Vice President Mike Pence coordinating the government's response and Trump at the podium taking questions from reporters during the press briefings, Fauci said it went from "the standard kind of scientifically based, public-health-based meetings" to "the anecdotally driven situations, the minimization, the president surrounding himself with people saying things that didn’t make any scientific sense."

"Then I started getting anxious that this was not going in the right direction," he told the newspaper. "We would say things like: 'This is an outbreak. Infectious diseases run their own course unless one does something to intervene.' And then he would get up and start talking about, 'It’s going to go away, it’s magical, it’s going to disappear.'"

That's when Fauci said it became clear to him that he needed to speak up, even if it meant contradicting the president.

"He would say something that clearly was not correct, and then a reporter would say, 'Well, let’s hear from Dr. Fauci.' I would have to get up and say, 'No, I’m sorry, I do not think that is the case,' he told the newspaper. "It isn’t like I took any pleasure in contradicting the president of the United States. I have a great deal of respect for the office. But I made a decision that I just had to. Otherwise I would be compromising my own integrity, and be giving a false message to the world. If I didn’t speak up, it would be almost tacit approval that what he was saying was OK."

This upset Trump's "inner circle," Fauci said.

"That’s when we started getting into things I felt were unfortunate and somewhat nefarious -- namely, allowing Peter Navarro to write an editorial in USA Today saying I’m wrong on most of the things I say," he told the newspaper. "Or to have the White House press office send out a detailed list of things I said that turned out to be not true -- all of which were nonsense because they were all true. The very press office that was making decisions as to whether I can go on a TV show or talk to you."

Fauci said there were a couple times where Trump even called him personally to say, "Hey, why aren’t you more positive? You’ve got to take a positive attitude. Why are you so negativistic? Be more positive."

Fauci said he and his family have received death threats, beginning last March, and that his wife once suggested he consider quitting.

"But I felt that if I stepped down, that would leave a void. Someone’s got to not be afraid to speak out the truth," he told the newspaper. "Even if I wasn’t very effective in changing everybody's minds, the idea that they knew that nonsense could not be spouted without my pushing back on it, I felt was important. I think in the big picture, I felt it would be better for the country and better for the cause for me to stay, as opposed to walk away."